Clinical Trials Browser

Active not recruiting × Neoadjuvant Therapy × Thoracic × Clear all

NCT05882513 2025-12-02

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04085250 2024-04-23

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung